-
1
-
-
0027533193
-
Osteosarcoma. Low-grade intraosseous-type osteosarcoma, histologically resembling parosteal osteosarcoma, fibrous dysplasia, and desmoplastic fibroma
-
Bertoni F, Bacchini P, Fabbri N, et al. Osteosarcoma. Low-grade intraosseous-type osteosarcoma, histologically resembling parosteal osteosarcoma, fibrous dysplasia, and desmoplastic fibroma. Cancer. 1993;71:338-345.
-
(1993)
Cancer
, vol.71
, pp. 338-345
-
-
Bertoni, F.1
Bacchini, P.2
Fabbri, N.3
-
2
-
-
18844383145
-
Dedifferentiated parosteal osteosarcoma: The experience of the Rizzoli Institute
-
Bertoni F, Bacchini P, Staals EL, et al. Dedifferentiated parosteal osteosarcoma: the experience of the Rizzoli Institute. Cancer. 2005;103:2373-2382.
-
(2005)
Cancer
, vol.103
, pp. 2373-2382
-
-
Bertoni, F.1
Bacchini, P.2
Staals, E.L.3
-
3
-
-
25444518461
-
MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: A comparative analysis of 559 soft tissue neoplasms with genetic data
-
Binh MB, Sastre-Garau X, Guillou L, et al. MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data. Am J Surg Pathol. 2005;29:1340-1347.
-
(2005)
Am J Surg Pathol.
, vol.29
, pp. 1340-1347
-
-
Binh, M.B.1
Sastre-Garau, X.2
Guillou, L.3
-
5
-
-
3242710448
-
Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: Histological review, genomic profile, and MDM2 and CDK4 status favour a single entity
-
Coindre JM, Hostein I, Maire G, et al. Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity. J Pathol. 2004;203:822-830.
-
(2004)
J Pathol.
, vol.203
, pp. 822-830
-
-
Coindre, J.M.1
Hostein, I.2
Maire, G.3
-
6
-
-
0037343252
-
Most malignant fibrous histiocytomas developed in the retroperitoneum are dedifferentiated liposarcomas: A review of 25 cases initially diagnosed as malignant fibrous histiocytoma
-
Coindre JM, Mariani O, Chibon F, et al. Most malignant fibrous histiocytomas developed in the retroperitoneum are dedifferentiated liposarcomas: a review of 25 cases initially diagnosed as malignant fibrous histiocytoma. Mod Pathol. 2003;16:256-262.
-
(2003)
Mod Pathol.
, vol.16
, pp. 256-262
-
-
Coindre, J.M.1
Mariani, O.2
Chibon, F.3
-
7
-
-
79955584243
-
MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone
-
Dujardin F, Binh MB, Bouvier C, et al. MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone. Mod Pathol. 2011;24:624-637.
-
(2011)
Mod Pathol.
, vol.24
, pp. 624-637
-
-
Dujardin, F.1
Binh, M.B.2
Bouvier, C.3
-
10
-
-
0345676507
-
Chromosomal organization of amplified chromosome 12 sequences in mesenchymal tumors detected by fluorescence in situ hybridization
-
Gisselsson D, Hoglund M, Mertens F, et al. Chromosomal organization of amplified chromosome 12 sequences in mesenchymal tumors detected by fluorescence in situ hybridization. Genes Chromosomes Cancer. 1998;23:203-212.
-
(1998)
Genes Chromosomes Cancer
, vol.23
, pp. 203-212
-
-
Gisselsson, D.1
Hoglund, M.2
Mertens, F.3
-
11
-
-
18244383816
-
Differentially amplified chromosome 12 sequences in low-and high-grade osteosarcoma
-
Gisselsson D, Palsson E, Hoglund M, et al. Differentially amplified chromosome 12 sequences in low-and high-grade osteosarcoma. Genes Chromosomes Cancer. 2002;33:133-140.
-
(2002)
Genes Chromosomes Cancer
, vol.33
, pp. 133-140
-
-
Gisselsson, D.1
Palsson, E.2
Hoglund, M.3
-
12
-
-
0036668010
-
Molecular analysis of p53, MDM2, and H-ras genes in osteosarcoma and malignant fibrous histiocytoma of bone in patients older than 40 years
-
Kawaguchi K, Oda Y, Sakamoto A, et al. Molecular analysis of p53, MDM2, and H-ras genes in osteosarcoma and malignant fibrous histiocytoma of bone in patients older than 40 years. Mod Pathol. 2002;15:878-888.
-
(2002)
Mod Pathol.
, vol.15
, pp. 878-888
-
-
Kawaguchi, K.1
Oda, Y.2
Sakamoto, A.3
-
13
-
-
33847612398
-
Dedifferentiated high-grade osteosarcoma originating from low-grade central osteosarcoma of the fibula
-
Kenan S, Ginat DT, Steiner GC. Dedifferentiated high-grade osteosarcoma originating from low-grade central osteosarcoma of the fibula. Skeletal Radiol. 2007;36:347-351.
-
(2007)
Skeletal Radiol.
, vol.36
, pp. 347-351
-
-
Kenan, S.1
Ginat, D.T.2
Steiner, G.C.3
-
14
-
-
0025265131
-
Low-grade intraosseous osteosarcoma
-
Kurt AM, Unni KK, McLeod RA, et al. Low-grade intraosseous osteosarcoma. Cancer. 1990;65:1418-1428.
-
(1990)
Cancer
, vol.65
, pp. 1418-1428
-
-
Kurt, A.M.1
Unni, K.K.2
McLeod, R.A.3
-
15
-
-
0027508958
-
MDM2 gene amplification in metastatic osteosarcoma
-
Ladanyi M, Cha C, Lewis R, et al. MDM2 gene amplification in metastatic osteosarcoma. Cancer Res. 1993;53:16-18.
-
(1993)
Cancer Res.
, vol.53
, pp. 16-18
-
-
Ladanyi, M.1
Cha, C.2
Lewis, R.3
-
16
-
-
0030964879
-
P53 and MDM2 alterations in osteosarcomas: Correlation with clinicopathologic features and proliferative rate
-
Lonardo F, Ueda T, Huvos AG, et al. p53 and MDM2 alterations in osteosarcomas: correlation with clinicopathologic features and proliferative rate. Cancer. 1997;79:1541-1547.
-
(1997)
Cancer
, vol.79
, pp. 1541-1547
-
-
Lonardo, F.1
Ueda, T.2
Huvos, A.G.3
-
17
-
-
2442701607
-
Deregulation of the G1 to S-phase cell cycle checkpoint is involved in the pathogenesis of human osteosarcoma
-
Lopez-Guerrero JA, Lopez-Gines C, Pellin A, et al. Deregulation of the G1 to S-phase cell cycle checkpoint is involved in the pathogenesis of human osteosarcoma. Diagn Mol Pathol. 2004;13:81-91.
-
(2004)
Diagn Mol Pathol.
, vol.13
, pp. 81-91
-
-
Lopez-Guerrero, J.A.1
Lopez-Gines, C.2
Pellin, A.3
-
18
-
-
77952087785
-
Characterization of the 12q15 MDM2 and 12q13-14 CDK4 amplicons and clinical correlations in osteosarcoma
-
Mejia-Guerrero S, Quejada M, Gokgoz N, et al. Characterization of the 12q15 MDM2 and 12q13-14 CDK4 amplicons and clinical correlations in osteosarcoma. Genes Chromosomes Cancer. 2010;49:518-525.
-
(2010)
Genes Chromosomes Cancer
, vol.49
, pp. 518-525
-
-
Mejia-Guerrero, S.1
Quejada, M.2
Gokgoz, N.3
-
19
-
-
0028384491
-
Parosteal osteosarcoma. A clinicopathological study
-
Okada K, Frassica FJ, Sim FH, et al. Parosteal osteosarcoma. A clinicopathological study. J Bone Joint Surg Am. 1994;76:366-378.
-
(1994)
J Bone Joint Surg Am.
, vol.76
, pp. 366-378
-
-
Okada, K.1
Frassica, F.J.2
Sim, F.H.3
-
20
-
-
0032991072
-
Analysis of SAS gene and CDK4 and MDM2 proteins in low-grade osteosarcoma
-
Ragazzini P, Gamberi G, Benassi MS, et al. Analysis of SAS gene and CDK4 and MDM2 proteins in low-grade osteosarcoma. Cancer Detect Prev. 1999;23:129-136.
-
(1999)
Cancer Detect Prev.
, vol.23
, pp. 129-136
-
-
Ragazzini, P.1
Gamberi, G.2
Benassi, M.S.3
-
21
-
-
44949151698
-
A comparison of intramedullary and juxtacortical low-grade osteogenic sarcoma
-
Schwab JH, Antonescu CR, Athanasian EA, et al. A comparison of intramedullary and juxtacortical low-grade osteogenic sarcoma. Clin Orthop Relat Res. 2008;466:1318-1322.
-
(2008)
Clin Orthop Relat Res.
, vol.466
, pp. 1318-1322
-
-
Schwab, J.H.1
Antonescu, C.R.2
Athanasian, E.A.3
-
22
-
-
0029926512
-
Conventional and dedifferentiated parosteal osteosarcoma. Diagnosis, treatment, and outcome
-
Sheth DS, Yasko AW, Raymond AK, et al. Conventional and dedifferentiated parosteal osteosarcoma. Diagnosis, treatment, and outcome. Cancer. 1996;78:2136-2145.
-
(1996)
Cancer
, vol.78
, pp. 2136-2145
-
-
Sheth, D.S.1
Yasko, A.W.2
Raymond, A.K.3
-
23
-
-
0031730336
-
Dedifferentiated parosteal osteosarcoma with high-grade osteoclast-rich osteogenic sarcoma at presentation
-
Shuhaibar H, Friedman L. Dedifferentiated parosteal osteosarcoma with high-grade osteoclast-rich osteogenic sarcoma at presentation. Skeletal Radiol. 1998;27:574-577.
-
(1998)
Skeletal Radiol.
, vol.27
, pp. 574-577
-
-
Shuhaibar, H.1
Friedman, L.2
-
24
-
-
0029937660
-
Ring chromosomes in parosteal osteosarcoma contain sequences from 12q13-15: A combined cytogenetic and comparative genomic hybridization study
-
Szymanska J, Mandahl N, Mertens F, et al. Ring chromosomes in parosteal osteosarcoma contain sequences from 12q13-15: a combined cytogenetic and comparative genomic hybridization study. Genes Chromosomes Cancer. 1996;16:31-34.
-
(1996)
Genes Chromosomes Cancer
, vol.16
, pp. 31-34
-
-
Szymanska, J.1
Mandahl, N.2
Mertens, F.3
-
25
-
-
32444449180
-
Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: Implications for therapy
-
Tovar C, Rosinski J, Filipovic Z, et al. Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy. Proc Natl Acad Sci USA. 2006;103:1888-1893.
-
(2006)
Proc Natl Acad Sci USA
, vol.103
, pp. 1888-1893
-
-
Tovar, C.1
Rosinski, J.2
Filipovic, Z.3
-
26
-
-
0033579870
-
CDK4 gene amplification in osteosarcoma: Reciprocal relationship with INK4A gene alterations and mapping of 12q13 amplicons
-
Wei G, Lonardo F, Ueda T, et al. CDK4 gene amplification in osteosarcoma: reciprocal relationship with INK4A gene alterations and mapping of 12q13 amplicons. Int J Cancer. 1999;80:199-204.
-
(1999)
Int J Cancer
, vol.80
, pp. 199-204
-
-
Wei, G.1
Lonardo, F.2
Ueda, T.3
-
28
-
-
0033590604
-
Co-amplification and overexpression of CDK4, SAS and MDM2 occurs frequently in human parosteal osteosarcomas
-
Wunder JS, Eppert K, Burrow SR, et al. Co-amplification and overexpression of CDK4, SAS and MDM2 occurs frequently in human parosteal osteosarcomas. Oncogene. 1999;18:783-788.
-
(1999)
Oncogene
, vol.18
, pp. 783-788
-
-
Wunder, J.S.1
Eppert, K.2
Burrow, S.R.3
-
29
-
-
0031689788
-
Clinicopathologic implications of MDM2, p53 and K-ras gene alterations in osteosarcomas: MDM2 amplification and p53 mutations found in progressive tumors
-
Yokoyama R, Schneider-Stock R, Radig K, et al. Clinicopathologic implications of MDM2, p53 and K-ras gene alterations in osteosarcomas: MDM2 amplification and p53 mutations found in progressive tumors. Pathol Res Pract. 1998;194:615-621.
-
(1998)
Pathol Res Pract.
, vol.194
, pp. 615-621
-
-
Yokoyama, R.1
Schneider-Stock, R.2
Radig, K.3
-
30
-
-
77956275003
-
Immunohistochemical analysis of MDM2 and CDK4 distinguishes low-grade osteosarcoma from benign mimics
-
Yoshida A, Ushiku T, Motoi T, et al. Immunohistochemical analysis of MDM2 and CDK4 distinguishes low-grade osteosarcoma from benign mimics. Mod Pathol. 2010;23:1279-1288.
-
(2010)
Mod Pathol.
, vol.23
, pp. 1279-1288
-
-
Yoshida, A.1
Ushiku, T.2
Motoi, T.3
|